We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2006 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00338819
First Posted: June 20, 2006
Last Update Posted: June 20, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Tel-Aviv Sourasky Medical Center
  Purpose

Purpose:

To test the hemodynamic profile generated by the MCS’s ActiveCare+SFT device in ventilated patients and compare it to that of the Kendall SCD Express.

Design:

Comparative, prospective study. Patients are their own controls.


Condition
DVT Prevention Ventilated Patients

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients

Further study details as provided by Tel-Aviv Sourasky Medical Center:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult ventilated patient (Age >18).
  • The patient or his guardian is able and voluntarily prepared to sign the Informed Consent Form.

Exclusion Criteria:

  • Known, preexisting DVT or PE.
  • Patient who is participating in another clinical trial.
  • Patient with contraindication to use of the device including patients with leg gangrene, recent skin graft or medical situations where increase venous and lymphatic return is undesirable.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00338819


Contacts
Contact: Sorkine, Prof 972-3-6973894 sorkine@tasmc.health.gov.il

Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Sorkine, Prof Tel-Aviv Sourasky Medical Center
  More Information

ClinicalTrials.gov Identifier: NCT00338819     History of Changes
Other Study ID Numbers: TASMC06SP156CTIL
First Submitted: June 18, 2006
First Posted: June 20, 2006
Last Update Posted: June 20, 2006
Last Verified: June 2006

Keywords provided by Tel-Aviv Sourasky Medical Center:
DVT prevention
Hemodynamic study
IPC
CECT